204
Participants
Start Date
March 10, 2023
Primary Completion Date
October 7, 2024
Study Completion Date
August 13, 2025
Ruxolitinib Cream
Ruxolitinib cream 1.5% twice daily (BID) during the vehicle controlled (DBVC)and open label treatment period (OLE).
Vehicle Cream
Ruxolitinib matching vehicle cream 1.5% twice daily (BID) during the vehicle controlled period (DBVC).
Hospital Universitario Reina Sofia, Córdoba
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
Dermatology Associates of Plymouth Meeting, Plymouth Meeting
Dermatology Associates Pc, Rockville
Universitatsklinikum Schleswig Holstein, Kiel
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia (Presidio Spedali Civili), Brescia
Wake Forest University, Winston-Salem
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Medical University of South Carolina, Charleston
Hospital Morvan, Brest
International Clinical Research Tennessee Llc, Murfreesboro
University Hospital of Saint Etienne, Saint-Etienne
Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu, Nantes
University Hospitals Cleveland Medical Center, Cleveland
UC Health, Llc, Cincinnati
Hospital de Manises, Manises
Revival Research Institute, Llc Troy, Troy
Clarkston Medical Group, Clarkston
Fachklinik Bad Bentheim Dermatologie, Bad Bentheim
University Medical Center Rwth Aachen, Aachen
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz
Hautarztpraxis Dr. Med. Matthias Hoffmann, Witten
Ospedali Riuniti Di Ancona, Torrette
Medisearch Clinical Trials, Saint Joseph
Asl 1 Avezzano L'Aquila Sulmona- Ospedale Regionale San Salvatore, Coppito
Universitats-Hautklink Tubingen, Tübingen
Johnson Dermatology, Fort Smith
Central Sooner Research, Norman
North Texas Center For Clinical Research Ntccr, Frisco
Center For Clinical Studies, Webster
Austin Institute For Clinical Research Aicr Pflugerville, Pflugerville
Azienda Ospedaliera Universitaria Policlinico 'Federico Ii', Napoli
Medical Dermatology Specialists Phoenix, Phoenix
Hospital Prive D'Antony, Antony
First Oc Dermatology, Fountain Valley
Azienda Ospedaliero Universitaria Policlinico G.Rodolico San Marco, Catania
Premier Clinical Research, Spokane
Clinical Research Chile Spa., Valdivia
Centro Medico Skinmed, Las Condes
Ciec - Centro Internacional de Estudios Cli-Nicos, Santiago
Conexa Investigacion Clinica S.A., Buenos Aires
Cedic Centro de Investigaciones Clinicas, Ciudad Autonoma Buenos Aires
Buenos Aires Skin, Ciudad Autonoma Buenos Aires
Psoriahue-Medicina Interdisciplinar, Ciudad Autonoma Buenos Aires
Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata
Fundacion Scherbovsky, Mendoza
Instituto de Especialidades de La Salud Rosario, Rosario
Centro de Investigaciones Medicas Tucuman, San Miguel de Tucumán
Ulb Hospital Erasme, Brussels
Cliniques Universitaires Ucl Saint-Luc, Brussels
Az Sint-Lucas, Ghent
Universitair Ziekenhuis Gent, Ghent
Universitair Ziekenhuis (Uz) Leuven, Leuven
Centre Hospitalier Universitaire de Liege - Sart Tilman, Liège
Chu Ucl Namur de Saint Elisabeth, Namur
Beacon Dermatology, Calgary
Simcomed Health Ltd, Barrie
Dermeffects, London
Research Toronto, Toronto
Centre de Recherche Saint-Louis, Québec
Universitaetsklinikum Carl Gustav Carus Tu Dresden, Dresden
Fondazione Policlinico Universitario Agostino Gemelli Irccs, Roma
Amsterdam University Medical Centre, Amsterdam
Bravis Ziekenhuis, Bergen op Zoom
Pratia McM Krakow, Krakow
ETG LODZ, Lodz
Kliniczny Szpital Wojewodzki Nr 1, Rzeszów
Clinical Research Group Sp. Z.O.O, Warsaw
High-Med Przychodnia Specjalistycza, Warsaw
Centralny Szpital Kliniczny Mswia, Warsaw
Hospital General Unviersitario de Alicante, Alicante
Lead Sponsor
Incyte Corporation
INDUSTRY